Medline's IPO Soars, Marking Year's Largest U.S. Debut
Photo by Tim Witzdam on Unsplash
Medline, a medical technology company, completed its IPO on December 18, 2025, trading on the Nasdaq under "MED." Opening at $29, the stock closed near $41, a 40-percent increase, establishing Medline's valuation around $54 billion and marking the year's largest U.S. debut, according to Medtech Magazine.
Key takeaways
- Medical technology company Medline completed a highly successful Initial Public Offering (IPO), marking the largest U
- debut of the year and a significant shift from its prior status as one of the nation's largest family-owned businesses
- Trading on the Nasdaq under the ticker symbol “MED,” Medline opened at $29 per share on December 18, 2025, and closed near $41, representing a surge of over 40 percent on its first day, according to Medtech Magazine
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.